A sharp drop in stress hormones after giving birth to a child may predispose some women to develop certain conditions in which the immune system attacks the body's own tissues.
Dana-Farber Cancer Institute researchers have discovered the long-sought molecular "switch" that regulates the liver’s production of glucose.
World-first research at the University of Otago in New Zealand could help reverse the world-wide epidemic of diabetes and significantly reduce heart disease. Results show a 20% improvement in the body’s ability to use insulin.
According to a new study, behavioral changes and improved preventive measures are required to rein in poorly controlled blood sugar and cholesterol in African Americans with diabetes.
Research at Georgetown University Medical Center has found that a combination of naturally occurring edible oils may be effective in treating Type II diabetes.
The Mouse Models of Diabetic Complications Consortium group at Duke University Medical Center has received a five-year grant totaling more than $3.5 million from the NIH to create new mouse models for diabetic kidney and heart disease.
An age-old drug may point to a brand new way to treat type 2 diabetes, according to scientists at Joslin Diabetes Center and the University of California in San Diego (UCSD).
The number of Americans who are hospitalized for stroke continues to increase, but the death rate is declining, according to a recent report.
FDA announces a voluntary recall of Micronase lots, Glyburide Tablets
Geron Corp. announced the publication on Monday of research demonstrating a way to grow human embryonic stem cells without using feeder cells from mice.
The FDA has approved the Premarket Approval Application for Dermagraft in the treatment of chronic foot ulcers in patients with diabetes.
Researchers at the Technion-Israel Institute of Technology have demonstrated that human embryonic stem cells can create insulin producing cells, a result that could signal an important step toward a cure for type 1 diabetes.
The American College of Endocrinology and the American Association of Clinical Endocrinologists today announced their recommendations for new diabetes screening and management guidelines.
At least 10 million Americans at high risk for type 2 diabetes can sharply lower their chances of getting the disease with diet and exercise, according to the findings of a major clinical trial.
Recent findings by researchers at NIDDK and Vanderbilt University indicate that the RDA of vitamin C may need to increase to 90 milligrams a day for young women.
Elevated blood levels of two inflammatory substances seem to be independent risk factors for type 2 diabetes, researchers report.